Evaluation of SureCore Plus Biopsy System
ConditionBPH
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-80
SponsorUro-1 Medical
About this trial
This is a post-market study of a cleared biopsy system. The quality of tissue cores varies with standard of care biopsy needles. The SureCore Plus biopsy system is being evaluated as to quality and volume of tissue from prostate biopsy as compared to standard of care biopsy needles.
Eligibility criteria
Qualifiers
Patient has BPH requiring a prostate biopsy
Able and willing to provide consent
Disqualifiers
Active infection
Subject participating in an other device study of the prostate
Trial design
Treatments tested in this trial
- Evaluation of two biopsy systems
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov